TRIS PHARMA INC FDA Approval ANDA 201295

ANDA 201295

TRIS PHARMA INC

FDA Drug Application

Application #201295

Application Sponsors

ANDA 201295TRIS PHARMA INC

Marketing Status

Prescription001
Prescription002

Application Products

001SOLUTION;ORAL325MG/15ML;7.5MG/15ML0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE
002SOLUTION;ORAL300MG/15ML;10MG/15ML0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE

FDA Submissions

N/A; Not ApplicableORIG1AP2021-12-30

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA
002PrescriptionAA

CDER Filings

TRIS PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201295
            [companyName] => TRIS PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG\/15ML;7.5MG\/15ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"300MG\/15ML;10MG\/15ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/30\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-12-30
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.